Desvenlafaxine Succinate (CAS NO : 93413-62-8)

Desvenlafaxine Succinate is primarily used to treat major depressive disorder (MDD) in adults by increasing the levels of serotonin and norepinephrine in the brain, which helps regulate mood.

It is typically taken once daily, with or without food. The tablets should be swallowed whole and not divided, crushed, chewed, or dissolved.

Common side effects include nausea, dizziness, and dry mouth. Serious side effects may include increased blood pressure, suicidal thoughts, and serotonin syndrome. Always consult your healthcare provider if you experience any unusual symptoms. Sexual dysfunction: Including decreased libido and difficulty achieving orgasm.

Desvenlafaxine Succinate is a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by inhibiting the reuptake of serotonin and norepinephrine in the brain, thus increasing their concentrations and helping to regulate mood.

Desvenlafaxine Succinate is approved by regulatory bodies such as the FDA for major depressive disorder in adults. It complies with cGMP standards for pharmaceutical manufacturing and is supported by DMF submissions for global markets.